The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GMP Cell Banking Services Market Research Report 2024
Synopsis
The creation of a regulatory-compliant cell bank is an essential component in the production of well characterised biopharmaceutical products. The use of qualified cell banks provides opportunity to detect and identify (and thereby exclude) possible contaminating adventitious agents such as viruses and mycoplasma prior to their use in manufacture.
The global GMP Cell Banking Services market was valued at US$ 189.1 million in 2023 and is anticipated to reach US$ 258 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.
This report aims to provide a comprehensive presentation of the global market for GMP Cell Banking Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cell Banking Services.
Report Scope
The GMP Cell Banking Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Cell Banking Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Cell Banking Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Covance
Segment by Type
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cell Banking Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The creation of a regulatory-compliant cell bank is an essential component in the production of well characterised biopharmaceutical products. The use of qualified cell banks provides opportunity to detect and identify (and thereby exclude) possible contaminating adventitious agents such as viruses and mycoplasma prior to their use in manufacture.
The global GMP Cell Banking Services market was valued at US$ 189.1 million in 2023 and is anticipated to reach US$ 258 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.
This report aims to provide a comprehensive presentation of the global market for GMP Cell Banking Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cell Banking Services.
Report Scope
The GMP Cell Banking Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Cell Banking Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Cell Banking Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Covance
Segment by Type
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cell Banking Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Cell Banking Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mammalian
1.2.3 Microbial
1.2.4 Insect
1.2.5 Yeast
1.2.6 Avian
1.2.7 Stem Cell
1.2.8 Others
1.3 Market by Application
1.3.1 Global GMP Cell Banking Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Manufacturing Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Cell Banking Services Market Perspective (2019-2030)
2.2 GMP Cell Banking Services Growth Trends by Region
2.2.1 Global GMP Cell Banking Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 GMP Cell Banking Services Historic Market Size by Region (2019-2024)
2.2.3 GMP Cell Banking Services Forecasted Market Size by Region (2025-2030)
2.3 GMP Cell Banking Services Market Dynamics
2.3.1 GMP Cell Banking Services Industry Trends
2.3.2 GMP Cell Banking Services Market Drivers
2.3.3 GMP Cell Banking Services Market Challenges
2.3.4 GMP Cell Banking Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Cell Banking Services Players by Revenue
3.1.1 Global Top GMP Cell Banking Services Players by Revenue (2019-2024)
3.1.2 Global GMP Cell Banking Services Revenue Market Share by Players (2019-2024)
3.2 Global GMP Cell Banking Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GMP Cell Banking Services Revenue
3.4 Global GMP Cell Banking Services Market Concentration Ratio
3.4.1 Global GMP Cell Banking Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Cell Banking Services Revenue in 2023
3.5 GMP Cell Banking Services Key Players Head office and Area Served
3.6 Key Players GMP Cell Banking Services Product Solution and Service
3.7 Date of Enter into GMP Cell Banking Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Cell Banking Services Breakdown Data by Type
4.1 Global GMP Cell Banking Services Historic Market Size by Type (2019-2024)
4.2 Global GMP Cell Banking Services Forecasted Market Size by Type (2025-2030)
5 GMP Cell Banking Services Breakdown Data by Application
5.1 Global GMP Cell Banking Services Historic Market Size by Application (2019-2024)
5.2 Global GMP Cell Banking Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America GMP Cell Banking Services Market Size (2019-2030)
6.2 North America GMP Cell Banking Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America GMP Cell Banking Services Market Size by Country (2019-2024)
6.4 North America GMP Cell Banking Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Cell Banking Services Market Size (2019-2030)
7.2 Europe GMP Cell Banking Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe GMP Cell Banking Services Market Size by Country (2019-2024)
7.4 Europe GMP Cell Banking Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Cell Banking Services Market Size (2019-2030)
8.2 Asia-Pacific GMP Cell Banking Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific GMP Cell Banking Services Market Size by Region (2019-2024)
8.4 Asia-Pacific GMP Cell Banking Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Cell Banking Services Market Size (2019-2030)
9.2 Latin America GMP Cell Banking Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America GMP Cell Banking Services Market Size by Country (2019-2024)
9.4 Latin America GMP Cell Banking Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Cell Banking Services Market Size (2019-2030)
10.2 Middle East & Africa GMP Cell Banking Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa GMP Cell Banking Services Market Size by Country (2019-2024)
10.4 Middle East & Africa GMP Cell Banking Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Detail
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec GMP Cell Banking Services Introduction
11.1.4 WuXi AppTec Revenue in GMP Cell Banking Services Business (2019-2024)
11.1.5 WuXi AppTec Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories GMP Cell Banking Services Introduction
11.2.4 Charles River Laboratories Revenue in GMP Cell Banking Services Business (2019-2024)
11.2.5 Charles River Laboratories Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Detail
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific GMP Cell Banking Services Introduction
11.3.4 Eurofins Scientific Revenue in GMP Cell Banking Services Business (2019-2024)
11.3.5 Eurofins Scientific Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA GMP Cell Banking Services Introduction
11.4.4 Merck KGaA Revenue in GMP Cell Banking Services Business (2019-2024)
11.4.5 Merck KGaA Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza GMP Cell Banking Services Introduction
11.5.4 Lonza Revenue in GMP Cell Banking Services Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 SGS Ltd
11.6.1 SGS Ltd Company Detail
11.6.2 SGS Ltd Business Overview
11.6.3 SGS Ltd GMP Cell Banking Services Introduction
11.6.4 SGS Ltd Revenue in GMP Cell Banking Services Business (2019-2024)
11.6.5 SGS Ltd Recent Development
11.7 ViruSure
11.7.1 ViruSure Company Detail
11.7.2 ViruSure Business Overview
11.7.3 ViruSure GMP Cell Banking Services Introduction
11.7.4 ViruSure Revenue in GMP Cell Banking Services Business (2019-2024)
11.7.5 ViruSure Recent Development
11.8 Austrianova
11.8.1 Austrianova Company Detail
11.8.2 Austrianova Business Overview
11.8.3 Austrianova GMP Cell Banking Services Introduction
11.8.4 Austrianova Revenue in GMP Cell Banking Services Business (2019-2024)
11.8.5 Austrianova Recent Development
11.9 Goodwin Biotechnology
11.9.1 Goodwin Biotechnology Company Detail
11.9.2 Goodwin Biotechnology Business Overview
11.9.3 Goodwin Biotechnology GMP Cell Banking Services Introduction
11.9.4 Goodwin Biotechnology Revenue in GMP Cell Banking Services Business (2019-2024)
11.9.5 Goodwin Biotechnology Recent Development
11.10 Paragon Bioservices
11.10.1 Paragon Bioservices Company Detail
11.10.2 Paragon Bioservices Business Overview
11.10.3 Paragon Bioservices GMP Cell Banking Services Introduction
11.10.4 Paragon Bioservices Revenue in GMP Cell Banking Services Business (2019-2024)
11.10.5 Paragon Bioservices Recent Development
11.11 BioReliance
11.11.1 BioReliance Company Detail
11.11.2 BioReliance Business Overview
11.11.3 BioReliance GMP Cell Banking Services Introduction
11.11.4 BioReliance Revenue in GMP Cell Banking Services Business (2019-2024)
11.11.5 BioReliance Recent Development
11.12 Sartorious
11.12.1 Sartorious Company Detail
11.12.2 Sartorious Business Overview
11.12.3 Sartorious GMP Cell Banking Services Introduction
11.12.4 Sartorious Revenue in GMP Cell Banking Services Business (2019-2024)
11.12.5 Sartorious Recent Development
11.13 BSL Bioservice
11.13.1 BSL Bioservice Company Detail
11.13.2 BSL Bioservice Business Overview
11.13.3 BSL Bioservice GMP Cell Banking Services Introduction
11.13.4 BSL Bioservice Revenue in GMP Cell Banking Services Business (2019-2024)
11.13.5 BSL Bioservice Recent Development
11.14 Cleancells
11.14.1 Cleancells Company Detail
11.14.2 Cleancells Business Overview
11.14.3 Cleancells GMP Cell Banking Services Introduction
11.14.4 Cleancells Revenue in GMP Cell Banking Services Business (2019-2024)
11.14.5 Cleancells Recent Development
11.15 Covance
11.15.1 Covance Company Detail
11.15.2 Covance Business Overview
11.15.3 Covance GMP Cell Banking Services Introduction
11.15.4 Covance Revenue in GMP Cell Banking Services Business (2019-2024)
11.15.5 Covance Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
